Effect of Ptyrone on diabetes
Phase 3
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2019/05/019446
- Lead Sponsor
- SSV Phytopharmaceuticals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Male and female aged 18 to 65 who are suffering from type 2 diabetes mellitus.
2.Willing to give informed consent.
Exclusion Criteria
1.Patients who are suffering from any other systemic illness other than type 2 diabetes mellitus or megaloblastic anaemia.
2.Patients who are on corticosteroids and oral contraceptives
3.Patients with seropositive status.
4.Pregnancy
5.Patients Participation in clinical trials evaluating investigational pharmaceuticals or biologics within 3 months or devices within 30 days of admission to the study.
6.History of alcohol. substance abuse or alcoholism, within the previous one year
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method